IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q2 2022 Holdings

Filed 2022-08-01 | 5 holdings | $6.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Candel Therapeutics Inc(CADL)COM137404109$6.3M1,935,21598.4%
Dice Therapeutics IncCOM23345J104$51.1K3,292,8710.8%
Isoplexis CorpCOM465005106$19.0K8,808,5310.3%
Codex DNA IncCOM192003101$17.7K9,844,1300.3%
Vigil Neuroscience Inc(VIGL)COM92673K108$10.9K4,214,4980.2%